Ra Pharmaceuticals, Inc. Contracts & Agreements

23 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
RA PHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT
Investor Rights Agreements
Ra Pharmaceuticals, Inc.
Pharmaceuticals
MA
2016
Second Amendment to Lease Agreement, dated March 11, 2020, by and between Ra Pharmaceuticals, Inc. and HCP/King 87 CPD LLC
Lease Agreements
Ra Pharmaceuticals, Inc.
2020
Description of Capital Stock
Stock Agreements
Ra Pharmaceuticals, Inc.
2020
License Agreement, dated as of July 15, 2019, by and between the Registrant and Camurus AB
License Agreements
Ra Pharmaceuticals, Inc.
2019
Agreement and Plan of Merger, dated October 9, 2019, by and among UCB S.A., Franq Merger Sub, Inc. and Ra Pharmaceuticals, Inc
Merger Agreements
Ra Pharmaceuticals, Inc.
Pharmaceuticals
DE
2019
Non-Employee Director Compensation Policy, effective April 1, 2019
Compensation Agreements
Ra Pharmaceuticals, Inc.
Pharmaceuticals
2019
Underwriting Agreement, dated July 23, 2019, between the Company and Jefferies LLC, BMO Capital Markets Corp. and Stifel, Nicolaus & Company, Incorporated, as representatives of...
Underwriting Agreements
Ra Pharmaceuticals, Inc.
2019
Open Market Sale AgreementSM, dated as of May 9, 2019, by and between Ra Pharmaceuticals, Inc. and Jefferies LLC
Ra Pharmaceuticals, Inc.
Pharmaceuticals
NY
2019
Underwriting Agreement, dated December 11, 2018, between the Company and Jefferies LLC, BMO Capital Markets Corp. and Stifel, Nicolaus & Company, Incorporated, as representatives...
Underwriting Agreements
Ra Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Non-Employee Director Compensation Policy
Compensation Agreements
Ra Pharmaceuticals, Inc.
Pharmaceuticals
2018
Sales Agreement, dated as of May 9, 2018, by and between Ra Pharmaceuticals, Inc. and Stifel, Nicolaus & Company, Incorporated
Sales Agreements
Ra Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Underwriting Agreement, dated February 14, 2018, between the Company and Credit Suisse Securities (USA) LLC, Jefferies LLC and BMO Capital Markets Corp., as representatives of the...
Underwriting Agreements
Ra Pharmaceuticals, Inc.
2018
RA PHARMACEUTICALS, INC. 2016 STOCK AWARD AND INCENTIVE PLAN
Bonus & Incentive Agreements
Ra Pharmaceuticals, Inc.
2016
RA PHARMACEUTICALS, INC. SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN
Bonus & Incentive Agreements
Ra Pharmaceuticals, Inc.
Pharmaceuticals
2016
RA PHARMACEUTICALS, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
Ra Pharmaceuticals, Inc.
Pharmaceuticals
DE
2016
RA PHARMACEUTICALS, INC. FORM OF DIRECTOR INDEMNIFICATION AGREEMENT
Indemnification Agreements
Ra Pharmaceuticals, Inc.
Pharmaceuticals
DE
2016
[ *** ] TEXT OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(B)(4) AND 240.24B-2...
Exchange Agreements
Ra Pharmaceuticals, Inc.
Pharmaceuticals
NY
2016
EXCLUSIVE LICENSE AGREEMENT by and between Anthony C. Forster, M.D., Ph.D. an individual and Ra Pharmaceuticals, Inc. a Delaware corporation
License Agreements
Ra Pharmaceuticals, Inc.
2016
Research and Development Collaboration and License agreement
Collaboration Agreements
Ra Pharmaceuticals, Inc.
2016
WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
Ra Pharmaceuticals, Inc.
Pharmaceuticals
DE
2016
RA PHARMACEUTICALS, INC. COMMON STOCK WARRANT Original Issue Date: December 1, 2010 Void After: 5 PM Boston Time on December 1, 2020 This Warrant Is Issued to Stephen C. Blacklow
Stock Agreements
Ra Pharmaceuticals, Inc.
2016
RA PHARMACEUTICALS, INC. 2010 STOCK OPTION AND GRANT PLAN
Stock Agreements
Ra Pharmaceuticals, Inc.
2016
[ *** ] TEXT OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(B)(4) AND 240.24B-2...
Exchange Agreements
Ra Pharmaceuticals, Inc.
Pharmaceuticals
NY
2016